Targeted Contrast Agent for Cancer Imaging (IMAGE)
Caption
The figure illustrates the concept of work. The targeted contrast agent, ZD2-Gd3N@C80, binds to aggressive tumor and produces strong signal enhancement, but not in slow-growing tumors, which allow detection and risk-stratification of breast cancer.
Credit
Case Western Reserve University
Usage Restrictions
None
License
Licensed content